Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000762170 | SCV000892435 | uncertain significance | not provided | 2018-04-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001050940 | SCV001215072 | uncertain significance | Charcot-Marie-Tooth disease type 4 | 2019-11-26 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine with arginine at codon 1204 of the SH3TC2 protein (p.Lys1204Arg). The lysine residue is highly conserved and there is a small physicochemical difference between lysine and arginine. This variant is present in population databases (rs143436632, ExAC 0.009%). This variant has not been reported in the literature in individuals with SH3TC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 624068). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Molecular Genetics Laboratory, |
RCV001173822 | SCV001336936 | uncertain significance | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing |